BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Diagnosis
14254 results:

  • 1. Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people.
    Liao Y; Li Z; Song L; Xue Y; Chen X; Feng G
    World J Surg Oncol; 2024 May; 22(1):135. PubMed ID: 38778366
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigastric Pain and Dysphagia in a 36-Year-Old Man Due to Primary Esophageal Small Cell Carcinoma.
    Aijaz P; Niazi MA; Chela HK; Zahid K; Daglilar E
    Am J Case Rep; 2024 May; 25():e943392. PubMed ID: 38773743
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
    Xing X; Li L; Sun M; Zhu X; Feng Y
    Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm.
    Chen JY; Yang H; Lin XD; Yang H; Wen J; Liu QW; Zhang LJ; Lin P; Fu JH; Leng CS; Yi R; Luo KJ
    Ther Adv Respir Dis; 2024; 18():17534666241249150. PubMed ID: 38757612
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
    Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Leveraging Serial Low-Dose CT Scans in Radiomics-based Reinforcement Learning to Improve Early diagnosis of lung cancer at Baseline Screening.
    Wang Y; Zhou C; Ying L; Lee E; Chan HP; Chughtai A; Hadjiiski LM; Kazerooni EA
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230196. PubMed ID: 38752718
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Influence of malnutrition according to the glim criteria on the chemotherapy toxicities in patients with advanced lung cancer.
    Li N; Xue D; Men K; Li L; Yang J; Jiang H; Meng Q; Zhang S
    Support Care Cancer; 2024 May; 32(6):358. PubMed ID: 38750262
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil.
    Campos MR; Rodrigues JM; Marques AP; Faria LV; Valerio TS; Silva MJSD; Pires DC; Chaves LA; Cardoso CHD; Campos SR; Emmerick ICM
    Rev Saude Publica; 2024; 58():18. PubMed ID: 38747866
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil.
    Bernardi FDC; Algranti E; Dolhnikoff M; Pinto CAL; Oliveira IM; Coletta ENAM; Silva ECAD; Nunes AJF; Veneziano DB; Luizaga CTM; Lorenzi RL; Silva DRME; Mauad T
    J Bras Pneumol; 2024; 50(2):e20230343. PubMed ID: 38747814
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Analysis on the ultrasonic characteristics of tonsillar lymphoma].
    Yue B; Zhu JL; Shi CL; Wang M; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):457-460. PubMed ID: 38742359
    [No Abstract]    [Full Text] [Related]  

  • 14. [Impact of obesity on the incidence of postoperative pulmonary complications following laparoscopic colorectal surgery].
    Wang TH; Li HX; Li BL; Zheng H; Yan T
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1610-1616. PubMed ID: 38742348
    [No Abstract]    [Full Text] [Related]  

  • 15. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
    Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
    [No Abstract]    [Full Text] [Related]  

  • 16. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
    Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
    BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
    Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
    BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk and prognosis of secondary lung cancer after radiation therapy for thoracic malignancies.
    Chen K; Liu C; Li X; Chen T; Liu S; Xiong F; Zhang Z
    Clin Respir J; 2024 May; 18(5):e13760. PubMed ID: 38725324
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An 18F-FDG-PET/CT-based radiomics signature for estimating malignance probability of solitary pulmonary nodule.
    Zheng J; Hao Y; Guo Y; Du M; Wang P; Xin J
    Clin Respir J; 2024 May; 18(5):e13751. PubMed ID: 38725315
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
    Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
    Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 713.